Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice

NCT00928408 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00928408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00928408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
February 29, 2012
Enrollment
305 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperparathyroidism, primary